Holen Sie sich die Stockscreener-App
104.32
0.26%
0.27
Vorhandelsmarkt:
104.32
Schlusskurs vom Vortag:
$104.05
Offen:
$104.81
24-Stunden-Volumen:
2.67M
Relative Volume:
1.68
Marktkapitalisierung:
$20.77B
Einnahmen:
$7.60B
Nettoeinkommen (Verlust:
$1.08B
KGV:
19.83
EPS:
5.26
Netto-Cashflow:
$1.26B
1W Leistung:
-0.49%
1M Leistung:
-4.71%
6M Leistung:
-9.65%
1J Leistung:
-16.11%
1-Tages-Spanne:
$102.42
$105.56
1-Wochen-Bereich:
$102.42
$107.64
52-Wochen-Spanne:
$97.69
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
104.32 | 20.77B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
138.01 | 239.35B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.79 | 153.17B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
386.19 | 147.36B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.02 | 118.00B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.62 | 42.24B | 5.72B | 4.17B | 490.10M | 6.97 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Zimmer Biomet announces definitive agreement to Acquire Paragon 28 - Today's Medical Developments
Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet Holdings (NYSE:ZBH) Has Affirmed Its Dividend Of $0.24 - Yahoo Finance
Is the Market Bullish or Bearish on Zimmer Biomet Holdings? - Benzinga
Prosthetic Disc Nucleus Market Outlook to Exceed US$ 265.8 Million by 2034, Driven by Minimally Invasive Surgery Innovations | Latest Report by Transparency Market Research Inc. - GlobeNewswire Inc.
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference - PR Newswire
Zimmer Biomet Announces New Schwarzenegger-Led Campaign - Pharmaceutical Executive
Tekcem bone cement: A breakthrough launch by Zimmer Biomet Holdings - Healthcare Radius
Zimmer Biomet’s $1.75 Billion Notes Offering - Global Legal Chronicle
Weil Advises Underwriters on Zimmer Biomet’s $1.75 Billion Notes Offering - Legal Desire News Network
Zimmer Biomet names Jehanzeb Noor as new strategy and innovation chief - Investing.com Canada
Can Zimmer Biomet's New Strategy Chief Transform Its Acquisition Approach? MIT-Educated Executive Takes Helm - StockTitan
Zimmer Biomet Launches You’ll Be Back Campaign With Chief Movement Officer Arnold Schwarzenegger - Times-Union Newspaper
Zimmer Biomet sets quarterly dividend at $0.24 per share By Investing.com - Investing.com Australia
Zimmer Biomet and Arnold Schwarzenegger promote joint health via new campaign - Yahoo Finance
Ivan Tornos to chair Zimmer Biomet board, company launches new campaign with Arnold Schwarzenegger - Mass Device
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025 - The Malaysian Reserve
Zimmer Biomet Launches You’ll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger - MultiVu
Zimmer Biomet Launches You'll Be Back Campaign With Chief Movement Officer Arnold Schwarzenegger - MENAFN.COM
Can Arnold Schwarzenegger Help Millions With Joint Pain? Zimmer Biomet's New Campaign Says Yes - StockTitan
Zimmer Biomet sets quarterly dividend at $0.24 per share - Investing.com
Zimmer Biomet names new chairman, lead independent director By Investing.com - Investing.com Canada
Zimmer Biomet names new chairman, lead independent director - Investing.com India
Zimmer Biomet Announces Upcoming Changes to Company's Board of Directors - PR Newswire
Zimmer Biomet launches Tekcem antibiotic bone cements in India - BSI bureau
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Zimmer Biomet Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Zimmer Biomet issues new notes, details merger agreement terms By Investing.com - Investing.com Nigeria
Zimmer Biomet issues new notes, details merger agreement terms - Investing.com
This Zimmer Biomet Holdings Insider Reduced Their Stake By 71% - Simply Wall St
Zimmer Biomet's SWOT analysis: medical device maker's stock faces ERP hurdles - MSN
Hourglass Capital LLC Has $7.12 Million Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink? - MSN
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, market expansion - Investing.com Nigeria
Zimmer Biomet enters a distribution agreement with Promamec in Morocco - ZAWYA
Rhumbline Advisers Reduces Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ZBH Stock Hurt by Margin Concerns and Difficult Solvency - Yahoo Finance
AlphaCentric Advisors LLC Makes New $623,000 Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
74,083 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Acquired by KLCM Advisors Inc. - MarketBeat
Legacy Capital Wealth Partners LLC Makes New Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Chevy Chase Trust Holdings LLC Trims Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
New York State Teachers Retirement System Has $17.82 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
MFG Wealth Management Inc. Acquires Shares of 14,259 Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet price target lowered to $111 from $122 at Bernstein - MSN
Van ECK Associates Corp Buys 218,688 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
4,201 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Purchased by Roman Butler Fullerton & Co. - MarketBeat
103,508 Shares in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Bought by Strategic Financial Concepts LLC - MarketBeat
Zimmer Biomet (NYSE:ZBH) Hits New 12-Month LowTime to Sell? - MarketBeat
Allspring Global Investments Holdings LLC Trims Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
State of Alaska Department of Revenue Sells 6,280 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Purchases 22,396 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):